NCT00003943View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

November 30, 2000

Study Completion Date

February 28, 2003

Conditions
Carcinoma of Unknown PrimaryLung Cancer
Interventions
BIOLOGICAL

filgrastim

5 ug/kg

DRUG

carboplatin

AUC 5

DRUG

cyclophosphamide

3 gm/m2

DRUG

paclitaxel

250 mg/m2

DRUG

topotecan hydrochloride

10 mg/m2

PROCEDURE

peripheral blood stem cell transplantation

harvest via apheresis

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

21231

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00003943 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | Biotech Hunter | Biotech Hunter